Avextra AG and SynQube GmbH announce a Strategic Partnership in Drug Development with Cannabinoids and other Psychotropic Substances
BENSHEIM, Germany, June 20, 2024 (GLOBE NEWSWIRE) — The leading European manufacturer and developer of Cannabis-based medicines, Avextra AG (“Avextra”), is proud to announce a strategic partnership in drug development with SynQube GmbH based in Offenbach, Ge…
- Avextra, the leading European vertically-integrated manufacturer and developer of cannabis-based medicines, is expanding its pharmaceutical development capabilities.
- Behind SynQube G…